Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-17-017962

President and CEO sold 4,781 shares at $15.70 ($75,062)

  • President and CEO acquired 4,781 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McCarthy Sean A. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-05-01 Exercise or conversion : show line 1 in the form +4,781 $0.95 $4,518 6,760 D
2017-05-01 Sale : show line 2 in the form −4,781 $15.70 $75,062 1,979 D
Open-market sales · 4,781 sh · avg $15.70 · $75,062

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-05-01 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −4,781 68,072 D
Loading xslF345X03/doc1.xml…